Dishman Carbogen Amcis Limited (DCAL.BO)

INR 193.4

(0.34%)

Total Liabilities Summary of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited's latest annual total liabilities in 2023 was 39.53 Billion INR , up 8.51% from previous year.
Dishman Carbogen Amcis Limited's latest quarterly total liabilities in 2023 FY was 39.53 Billion INR , up 8.51% from previous quarter.
Dishman Carbogen Amcis Limited reported annual total liabilities of 36.43 Billion INR in 2022, up 17.98% from previous year.
Dishman Carbogen Amcis Limited reported annual total liabilities of 30.88 Billion INR in 2021, up 15.79% from previous year.
Dishman Carbogen Amcis Limited reported quarterly total liabilities of 39.53 Billion INR for 2023 Q4, down 0.0% from previous quarter.
Dishman Carbogen Amcis Limited reported quarterly total liabilities of 37.3 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Dishman Carbogen Amcis Limited (2023 - 2005)

Historical Annual Total Liabilities of Dishman Carbogen Amcis Limited (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	39.53 Billion INR	8.51%
2022	36.43 Billion INR	17.98%
2021	30.88 Billion INR	15.79%
2020	26.67 Billion INR	7.38%
2019	24.83 Billion INR	27.42%
2018	19.49 Billion INR	-5.79%
2017	20.69 Billion INR	16.28%
2016	17.79 Billion INR	16.42%
2015	15.28 Billion INR	-2.71%
2014	15.71 Billion INR	8.32%
2013	14.5 Billion INR	15.09%
2012	12.6 Billion INR	-4.53%
2011	13.2 Billion INR	9.55%
2010	12.05 Billion INR	19.55%
2009	10.08 Billion INR	6.12%
2008	9.49 Billion INR	6.0%
2007	8.96 Billion INR	6.32%
2006	8.42 Billion INR	107.07%
2005	4.07 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q1	- INR	-100.0%
2023 Q4	39.53 Billion INR	0.0%
2023 Q2	37.3 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2023 FY	39.53 Billion INR	8.51%
2022 Q3	- INR	-100.0%
2022 FY	36.43 Billion INR	17.98%
2022 Q4	36.43 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q2	32.72 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 FY	30.88 Billion INR	15.79%
2021 Q2	27.35 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q4	30.88 Billion INR	0.0%
2020 FY	26.67 Billion INR	7.38%
2020 Q2	23.73 Billion INR	0.0%
2020 Q4	26.67 Billion INR	0.0%
2019 FY	24.83 Billion INR	27.42%
2019 Q2	22.93 Billion INR	0.0%
2019 Q4	24.83 Billion INR	0.0%
2018 FY	19.49 Billion INR	-5.79%
2018 Q4	19.49 Billion INR	0.0%
2018 Q2	22.92 Billion INR	0.0%
2017 FY	20.69 Billion INR	16.28%
2017 Q2	18.39 Billion INR	0.0%
2017 Q4	20.69 Billion INR	0.0%
2016 FY	17.79 Billion INR	16.42%
2016 Q4	17.79 Billion INR	0.0%
2016 Q2	14.08 Billion INR	0.0%
2015 FY	15.28 Billion INR	-2.71%
2015 Q4	15.28 Billion INR	0.0%
2015 Q2	15.06 Billion INR	0.0%
2014 Q2	14.23 Billion INR	0.0%
2014 FY	15.71 Billion INR	8.32%
2014 Q4	15.71 Billion INR	0.0%
2013 Q2	14.34 Billion INR	0.0%
2013 Q4	14.5 Billion INR	0.0%
2013 FY	14.5 Billion INR	15.09%
2012 FY	12.6 Billion INR	-4.53%
2012 Q4	12.6 Billion INR	0.0%
2011 Q4	13.2 Billion INR	0.0%
2011 FY	13.2 Billion INR	9.55%
2010 FY	12.05 Billion INR	19.55%
2009 FY	10.08 Billion INR	6.12%
2008 FY	9.49 Billion INR	6.0%
2007 FY	8.96 Billion INR	6.32%
2006 FY	8.42 Billion INR	107.07%
2005 FY	4.07 Billion INR	0.0%

Peer Total Liabilities Comparison of Dishman Carbogen Amcis Limited

Name	Total Liabilities	Total Liabilities Difference
Alfavision Overseas (India) Limited	1.36 Billion INR	-2794.674%
Biocon Limited	307.95 Billion INR	87.161%
Blue Jet Healthcare Limited	2.13 Billion INR	-1750.854%
Concord Biotech Limited	1.74 Billion INR	-2171.505%
FERMENTA BIOTECH LIMITED	2.62 Billion INR	-1405.267%
GENOMIC VALLEY BIOTECH LIMITED	7.91 Million INR	-499367.985%
Lyka Labs Limited	884.58 Million INR	-4369.713%
Panacea Biotec Limited	4.02 Billion INR	-883.496%
SAMSRITA LABS LIMITED	32.93 Million INR	-119950.099%
Servoteach Industries Limited	5275.00 INR	-749544923.697%
SMS Lifesciences India Limited	1.96 Billion INR	-1908.226%
Supriya Lifescience Limited	1.05 Billion INR	-3634.627%
Syngene International Limited	18.93 Billion INR	-108.768%
TAKE Solutions Limited	969.78 Million INR	-3977.059%
Titan Biotech Limited	231.28 Million INR	-16994.995%
Transgene Biotek Limited	393.11 Million INR	-9957.846%
Vanta Bioscience Limited	724.23 Million INR	-5359.347%